NCT05239884View on ClinicalTrials.gov

CSD201202: A Study to Assess Nicotine Uptake From Electronic Nicotine Delivery System P12

NACompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

March 14, 2022

Primary Completion Date

April 15, 2022

Study Completion Date

April 15, 2022

Conditions
SmokingTobacco Use
Interventions
OTHER

ENDS Product A with 1.5% nicotine

P1211216, an Electronic Nicotine Delivery System (ENDS) with 1.5% nicotine

OTHER

ENDS Product B with 1.5% nicotine

P1213516, an Electronic Nicotine Delivery System (ENDS) with 1.5% nicotine

OTHER

ENDS Product C with 1.5% nicotine

P1213416, an Electronic Nicotine Delivery System (ENDS) with 1.5% nicotine

OTHER

ENDS Product D with 1.5% nicotine

P1212716, an Electronic Nicotine Delivery System (ENDS) with 1.5% nicotine

OTHER

ENDS Product E with 1.5% nicotine

P1213716, an Electronic Nicotine Delivery System (ENDS) with 1.5% nicotine

OTHER

ENDS Product F with 1.5% nicotine

P1213816, an Electronic Nicotine Delivery System (ENDS) with 1.5% nicotine

OTHER

ENDS Product G with 1.5% nicotine

P1211916, an Electronic Nicotine Delivery System (ENDS) with 1.5% nicotine

OTHER

ENDS Product H with 1.5% nicotine

P1210016, an Electronic Nicotine Delivery System (ENDS) with 1.5% nicotine

Trial Locations (1)

27265

High Point Clinical Trials Center, High Point

All Listed Sponsors
lead

RAI Services Company

INDUSTRY